Related Experiment Videos
Antibiotic bead chains
1Unfallklinik, Frankfurt am Main, Germany.
Abstract:
Gentamicin-PMMA chains are an effective drug delivery system for local antibiotic therapy in bone and soft-tissue infections. The gentamicin concentrations at the site of infection are far higher than after systemic application of the same antibiotic and far above the minimal inhibitory concentrations of most common pathogens. Because of the very low concentrations in the serum and urine after implantation of the antibiotic bead chains, toxic side effects are not to be feared. Radical debridement with removal of all sequestrated bone fragments and removal of all alloplastic implants is mandatory before implantation of gentamicin-PMMA chains into the infected bone cavity. Primary wound closure is necessary to achieve high local concentrations. The chains can be used for temporary or permanent filling of osteomyelitic cavities. Guidelines are given for the clinical application in sequestrating osteomyelitis, infected osteosynthesis, and infected pseudarthrosis. There are distinct advantages of this new form of antibiotic therapy in chronic osteomyelitis, such as increased patient comfort by primary wound closure, no need for prolonged systemic antibiotic therapy with toxic side effects, no irrigation-suction-drainage, early ambulation, shortening of hospitalization, and reduced cost.
Insights
Gentamicin-PMMA chains offer effective local antibiotic delivery for bone infections, achieving high concentrations with minimal systemic toxicity. This method enhances patient comfort and reduces hospitalization for chronic osteomyelitis treatment.
Area of Science:
- Orthopedics
- Infectious Diseases
- Biomaterials
Background:
- Chronic osteomyelitis and bone infections pose significant treatment challenges.
- Systemic antibiotic therapy often leads to toxicity and sub-optimal drug concentrations at the infection site.
- Local antibiotic delivery systems aim to overcome these limitations.
Observation:
- Gentamicin-polymethylmethacrylate (PMMA) chains provide sustained local release of gentamicin.
- High gentamicin concentrations are achieved directly at the infection site, exceeding minimal inhibitory concentrations for common pathogens.
- Serum and urine gentamicin levels remain very low, minimizing the risk of systemic toxicity.
Findings:
- Radical debridement and removal of infected bone/implants are crucial prior to gentamicin-PMMA chain implantation.
- Primary wound closure is essential for maintaining high local antibiotic concentrations.
- Gentamicin-PMMA chains can be used for temporary or permanent filling of infected bone cavities.
Implications:
- This approach offers significant advantages for treating chronic osteomyelitis, including sequestrating osteomyelitis, infected osteosynthesis, and infected pseudarthrosis.
- Benefits include enhanced patient comfort via primary wound closure, elimination of prolonged systemic antibiotic use, and avoidance of irrigation-suction-drainage.
- The method facilitates early ambulation, shortens hospitalization, and reduces overall treatment costs.